Near-complete gut genome catalogue from 41 countries sharpens how we model microbial metabolism
A catalogue of 155,211 near-complete gut microbial genomes from 41 countries enables more reliable metabolic models and links microbial interactions to disease.
Riepilogo
Researchers built HRGM2, an expanded Human Reference Gut Microbiome resource containing 155,211 non-redundant, near-complete genomes from 4,824 prokaryotic species across 41 countries. Every genome meets strict quality thresholds (at least 90% complete, no more than 5% contaminated). That is a 66% increase in genomes and a 50% increase in species compared with the Unified Human Gastrointestinal Genome catalogue. The authors report that the resource improves DNA-based species profiling, helps resolve strain-level differences, and supports surveys of antibiotic resistance genes in the gut. Using only high-quality genomes also allowed automated genome-scale metabolic models of whole gut communities, which the authors say reveal disease-associated metabolic interactions among microbes. The work is a foundational tool for microbiome science rather than a clinical trial, but it could make future gut-health and aging research more reliable.
Riepilogo Dettagliato
Gut microbiome research depends on reference genome catalogues, but many are geographically narrow and rely on medium-quality metagenome-assembled genomes (MAGs) that can miss up to half of a genome. Missing regions can distort inferences about what microbes can actually do metabolically, which matters for studies linking the microbiome to aging, metabolic disease, and immunity.
The authors built an enhanced Human Reference Gut Microbiome resource, HRGM2, restricted to near-complete MAGs (at least 90% completeness, no more than 5% contamination) plus isolate genomes. The catalogue spans samples from 41 countries.
HRGM2 contains 155,211 non-redundant genomes representing 4,824 prokaryotic species. Compared with the Unified Human Gastrointestinal Genome catalogue, this is a 66% rise in genome count and a 50% rise in species diversity. According to the abstract, the catalogue improved DNA-based species profiling, allowed better resolution of strain heterogeneity, and enabled a survey of the human gut resistome (the collection of antibiotic resistance genes). Using only near-complete genomes also improved assessment of metabolic capacity and allowed high-confidence, automated genome-scale metabolic models of the entire microbiota. The authors say these models revealed disease-associated microbial metabolic interactions.
For longevity and clinical audiences, the practical value is indirect: better reference genomes should make future microbiome studies, including those on aging-related conditions, more accurate and comparable across populations. Metabolic modeling could eventually help identify microbial pathways or interactions worth targeting.
Caveats: only the abstract was available, so specific methods, validation performance, and the diseases examined are not detailed here. Metabolic models are predictions, not direct measurements, and disease associations are correlational. One senior author is a founder and shareholder of DECODE BIOME, a disclosed competing interest.
Risultati Principali
- HRGM2 contains 155,211 non-redundant near-complete genomes from 4,824 prokaryotic species across 41 countries.
- Genome count rose 66% and species diversity 50% versus the Unified Human Gastrointestinal Genome catalogue.
- Near-complete genomes (≥90% complete, ≤5% contaminated) improved DNA-based species profiling and strain heterogeneity resolution.
- The resource enabled a survey of the human gut resistome.
- Automated, high-confidence genome-scale metabolic models of whole microbiota revealed disease-associated microbial metabolic interactions.
Metodologia
The authors assembled a catalogue of near-complete metagenome-assembled genomes and isolate genomes, applying thresholds of at least 90% completeness and no more than 5% contamination, and compared it with the Unified Human Gastrointestinal Genome catalogue. They applied it to species profiling, strain-level analysis, resistome surveys, and automated genome-scale metabolic modeling of gut communities. Details are limited to the abstract.
Limitazioni dello Studio
Only the abstract was reviewed, so validation metrics, specific diseases analyzed, and population representation within the 41 countries are unclear. Metabolic models are computational predictions and disease associations are not proof of causation. A senior author has a disclosed commercial interest in DECODE BIOME.
Ti è piaciuto questo riepilogo?
Ricevi ogni settimana le ultime ricerche sulla longevità direttamente nella tua casella email.
Inserisci la tua email per iscriverti: